FAQs

The 11th Microbiome Movement USA Summit is the industry's leading strategy-focused meeting dedicated to advancing microbiome therapeutics from early development through to clinical and commercial success. The event takes place November 9-11, 2026 in Boston, MA.

The summit focuses on helping microbiome companies secure regulatory approval, attract investment and pharma partnerships, advance clinical development, and unlock commercial success for LBPs and FMT therapies.

This summit is designed for microbiome professionals across clinical development, translational science, R&D, CMC, and manufacturing, from Scientists and Managers through to Directors, Heads, and C-suite leaders. A key differentiator of the meeting is its cross-functional audience, bringing together microbiome drug developers alongside regulators, investors, academics, and strategic partners to drive the advancement of microbiome therapeutics.

The 11th Microbiome Movement USA Summit is the only microbiome meeting focused specifically on advancing therapies towards regulatory approval, investment, and commercial success. With regulatory participation, leading investors, interactive workshops, and a highly senior audience of decision-makers, the summit delivers the insights and connections needed to accelerate your program.

Topics include clinical development, microbiome mechanisms of action, FDA engagement, manufacturing and CMC strategy, assay validation, fundraising, pharma partnering, translational science, and commercialization across indications including IBD, gut-brain-axis disorders, oncology, dermatology, and C. difficile.

Learn more about what's on here.

Attendees can connect through dedicated 8+ hours of networking breaks, speed networking sessions, roundtable discussions, workshops, poster sessions, and informal networking throughout the event.

Solution providers can showcase their expertise and connect directly with microbiome companies seeking support across manufacturing, analytics, sequencing, clinical strategy and preclinical models. Sponsorship, exhibition, and speaking opportunities are available.

Learn more about partnership opportunities here.

Yes. We offer team discounts of 10% for 2 attendees, 15% for 3 attendees, and 20% for 4+ attendees. Organizations including Gut-Brain-Axis Therapeutics and Exegi Pharmaceuticals have already taken advantage of group booking savings. Additional early bird discounts are also available. Click here to find out more.

For registration, speaking, sponsorship, or general enquiries, contact the team at info@hansonwade.com or call +1 617 455 4188. You can also visit www.microbiome-summit.com for the latest event information.